Related Experiment Video
Updated: Jun 26, 2025
02:41
Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding
Published on: May 3, 2024
1.5K
Pain management in cervical cancer.
Sebastián Aguiar-Rosas1,2, Ricardo Plancarte-Sanchez1,2, B Carolina Hernandez-Porras1,2
1Pain Clinic, Instituto Nacional de Cancerología, Mexico City, Mexico.
Frontiers in Oncology
|May 10, 2024
Summary
Cervical cancer pain management in Mexico needs better strategies. This study reviews current approaches and recommends comprehensive, individualized care using both medication and interventional pain management for advanced disease.
Area of Science:
- Oncology
- Pain Management
- Public Health
Background:
- Cervical cancer (CC) is a leading cause of cancer-related death in Mexican women.
- Late diagnosis of CC often results in severe complications, including debilitating pain.
- Pain affects up to 86% of patients with advanced cervical cancer, significantly impacting quality of life.
Purpose of the Study:
- To review the current literature on pain management in cervical cancer.
- To provide concise, evidence-based recommendations for effective pain control in CC patients.
- To address the gap in understanding and describing optimal pain management strategies for this population.
Main Methods:
- A comprehensive literature review on cervical cancer and pain management was conducted.
- Evidence was evaluated by experts in the field of pain management.
- Recommendations were formulated based on the reviewed evidence.
Main Results:
- The current approach to pain management in cervical cancer is not fully studied or described.
- There is a significant need for clear guidelines to ensure adequate pain control.
- Pharmacologic and interventional pain management strategies are crucial.
Conclusions:
- Pain management in cervical cancer requires a comprehensive and individualized approach.
- Timely and appropriate use of pharmacologic treatments is essential.
- Interventional pain management procedures should be considered as part of a multimodal strategy.
Related Concept Videos
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159
01:25Analgesia and Pain Management
584
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
584
01:11Local Anesthetics: Clinical Application as Spinal Anesthesia
620
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
620
01:31Skeletal Muscle Relaxants: Therapeutic Uses
481
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
481
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
231
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
231
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
429
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
429